Craif
Tokyo, JP · Founded 2018 · Japan corporation · 55 employees on LinkedIn · 14 known investors
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
Founders & leadership
Craif was founded in 2018 by Ryuichi Onose.
Investors · 14
.png){kind=logo}
Also in the syndicate · 11
Funding
SEC filings, press & company announcements$11.3M disclosed across 1 of 3 rounds · 2021–2025
- Undisclosed amountSeries CMay 2025
X&KSK (lead), Aozora Bank Group, Daiwa House Industry, TAUNS Laboratories, Unreasonable Group
Source ↗ - Undisclosed amountSeries CApr 2025
X&KSK (lead), Aozora Bank Group, Aozora Corporate Investment Co., Ltd., Daiwa House Industry Co., Ltd., MR Co., Ltd., TAUNS Laboratories, Inc., Toyoda Gosei Co., Ltd., TOYOTA BOSHOKU CORPORATION, Unreasonable Group, Unreasonable Syndicate
Source ↗
▶$11.3MraisedNov 2021 · 4 investors · Other Health CareRule 506(b)
- Ryuichi OnoseExecutive Officer, Director
- Yuki IchikawaDirector
- Mika YuiDirector
- Offering amount
- $26.9M
- Amount sold
- $11.3M
- First sale
- Oct 2021
- Incorporated
- Corporation, Japan, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Craif do?
- Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
- Who founded Craif?
- Craif was founded by Ryuichi Onose in 2018.
- Who are Craif's investors?
- Craif's investors include 1955 Capital, Global Brain, Aozora Corporate Investment.
- How much funding has Craif raised?
- Craif has disclosed $11.3M raised across 1 of its 3 known rounds.
- Where is Craif headquartered?
- Craif is headquartered in Tokyo, JP.